Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

featured

Published in Obesity, Metabolic Syndrome, and Prediabetes and

Journal Scan / Research · May 03, 2019

Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks

Circulation

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Peter Lin MD, CCFP

Circulation

Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks: Findings From the Swedish National Diabetes Registry

Circulation 2019 Apr 08;[EPub Ahead of Print], N Sattar, A Rawshani, S Franzén, A Rawshani, AM Svensson, A Rosengren, DK McGuire, B Eliasson, S Gudbjörnsdottir

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Obesity, Metabolic Syndrome, and Prediabetes

Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks

Additional Info

Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks: Findings From the Swedish National Diabetes Registry

Further Reading

Once-Weekly Semaglutide in Individuals With Obesity and Knee Osteoarthritis

Associations of Diabetes and Prediabetes With Mortality and Life Expectancy in Chinese Individuals

The Burden of Diabetes-Associated Multiple Long-Term Conditions on Years of Life Spent and Lost

Impact of GLP-1 Receptor Agonist–Based Treatments on Fat-Free Mass

Association Between Ultraprocessed Food Consumption and the Risk of Diabetes

Association of Glycaemic Risk Factors and Diabetes Duration With the Risk of Heart Failure in People With Type 2 Diabetes

Outcomes of Time-Restricted Eating in Adults With Metabolic Syndrome

Impact of Overweight and Obesity on Health Outcomes in the US From 1990 to 2021

The Effect of Semaglutide on Mortality and COVID-19–Related Deaths

Impact of GLP-1 RAs on Cardiorenal Outcomes and Mortality in People With Type 2 Diabetes and Acute Kidney Disease

SGLT2 Inhibitors in Hospitalised Patients With COVID-19

Recently Updated